In AGS gastric cancer cells, des (1-3) IGF-1 stimulated growth in a dose-dependent manner.
In plain wordsIn cells, des (1-3) IGF-1 increased gastric cancer cell growth with increasing dose.
- Peptide
- IGF-1 DES (des(1-3)IGF-I)
- Outcome
- IncreaseCell growth
- Study
humann: not reported in source
AGS gastric cancer cells- Outcome group
- Tumor growth · Cancer
- Studied dose
- Dose not stated
Source sentences
des (1-3) IGF-1, a truncated IGF-1 with very low affinity to IGFBPs, stimulated AGS cell growth in dose-dependent fashion.